Launched in June 2008, The Charles Institute at UCD is the first academic institute devoted to dermatology in Ireland. The Institute's vision is to become a world leader in dermatology research and training, which will lead to improved patient care through the discovery of new treatments and therapies.
Under the directorship of Professor Wolf Henning Boehncke, the new 2,000m2 institute on the UCD campus was largely funded by the Board of the City of Dublin Skin and Cancer Hospital from the sale of their Hume Street Hospital site, with University College Dublin contributing the remaining funds.
The research at The Charles Institute addresses common skin diseases such as psoriasis, eczema, skin cancer and rare genetic skin diseases. The research objectives of the Charles Institute are to:
The application of frontier biotechnologies will provide exciting opportunities to develop new therapies for the benefit of the patient. These will include:
The Charles Institute Seminar Series has been running since October 2009, with the aim of bringing together leading international experts to speak on the latest advances in dermatology.
The Charles Institute is a partnership between the UCD School of Medicine and Medical Science; affiliated teaching hospitals, St Vincent's University Hospital and Mater Misericordiae University Hospital; and the Board of the City of Dublin Skin and Cancer Hospital Charity.
